Clinical Trial Update: Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and excretion study of radiolabeled etelcalcetide in patients with end-stage renal disease on dialysis; completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism in Patients with Esrd On Hemodialysis

Drugs mentioned

• Etelcalcetide (etelcalcetide)

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis | Phase 1 | Status: COMPLETED | Results posted: 2017-04-14